Skip to main content
. 2016;17(11):4875–4883. doi: 10.22034/APJCP.2016.17.11.4875

Table 1.

Summary of Included Reviews

Study Treatment Search time Included study No. Results Conclusions Evidence level
Devoogdt 2010 CPT - 2 The overall improving in the CPT group was shown to be greater than the SP group but when the evaluation results of both groups were compared before and after treatment, a significant statistical difference in edema according to circumferential and volumetric measurements results was found in favor of CPT. In the patients with upper extremity LE, the shoulder mobility can be increased and edema can be decreased by the use of CPT. low
Ezzo 2015 MLD 2013.5.24 6 MLD + standard physiotherapy versus standard physiotherapy: no statistically significant between-groups difference in per cent reduction MLD is safe and may offer additional benefit to CB for swelling reduction. very low
MLD +CB vs. CB: LE volume: -60.73 (-194.43 72.96); volume reduction: 26.21 (-1.04 53.45); per cent reduction: 7.11% (1.75% 12.47%) In trials where MLD and sleeve were compared with a nonMLD treatment and sleeve, volumetric outcomes were inconsistent within the same trial. For symptoms such as pain and heaviness, 60% to 80% of participants reported feeling better regardless of which treatment they received.
CS + MLD vs. CS+ IPD: LE volume: 122 (-57.59 301.59); volume reduction: 47 (15.25 78.75); per cent reduction: 8 (-0.75 16.75)
CS + MLD vs. CS + SLD: LE volume: -230 (-450.84 -9.16); volume reduction: 10 (-90.54 110.54); per cent reduction:-2.40 (-14.11 9.31)
MLD + CB vs. SLD + CB: per cent reduction: 11.80 (-2.47 26.07)
Huang 2013 MLD 2012,12 10 MLD + standard treatment vs. standard treatment reduction in arm volume: 75.12 (−9.34 159.58) The addition of MLD to compression and exercise therapy for BCRL is unlikely to produce a significant reduction in LE volume. very low
Shao 2014 IPC 2013.12.20 7 The percent of volume reduction: CPT +IPC vs. CPT 4.51 (–7.01, 16.03). Both CDP and IPC could improve symptoms, but no differences existed between CPT +IPC and CPT. Current trials fail to show the effectiveness of the addition of IPC to the routine management of BCRL. very low
Singh 2015 Exercise 2015,1.1 25 LE volume: Single bout of exercise -0.1 (-0.3 0.1); Regular exercise -0.1, (-0.3 0.4); Exercise vs. control: -0.1 (-0.3 0.1); Exercise + compression vs. exercise : -0.2 (-0.5 0.1) Exercise, irrespective of mode, appeared to have no effect on LE and related symptoms. low
Heaviness: Single bout of exercise 0.0 (-0.3 0.3) There were no benefit of wearing compression for LE and associated symptoms, and exercise without compression does not exacerbate LE.
Tightness: Single bout of exercise0.1 (-0.3 0.4)
pain: Regular exercise vs. control: -0.1 (-0.6 0.1)
Poage 2015 botanicals (coumarin, BN165 (gamma benzopyrone)) 2011 2 The LE volume increased by 21 ml during placebo treatment and 58 ml during coumarin treatment (P=0.80). Evidence supporting the use of botanicals for the treatment of BCRL is insufficient. low
Moseley 2007 Daflon /Cyclo-fort/ 2004 01/01/2001 Daflon did not have significant difference in evolution of lymphedema volume in comparison with placebo, despite a tendency in favor of Daflon. 5,6–benzo-[alpha] -pyrone achieved a statistical significance in lymphedema volume reductions and percent reduction as compared with placebo. Varying volume reductions and subjective improvements could be obtained from oral pharmaceuticals such as Daflon (1000 mg) and Cyclo-fort, with the greatest limb reduction (840 ml, 35.6%) being obtained from the 5–6 Benzo-a-pyrone (200 mg).
5–6 Benzo- a-pyrone For Cyclo-fort the reduction in volume of arm edema was 12.9% after 3 months of treatment as compared with a placebo (p=0.009).
Leung 2015 Surgery 2014.2 03/02/2006 Liposuction reduces the volume and symptoms of LE, but requires continual compressive therapy to avoid recurrence. Lymphatic reconstruction or bypass techniques show promise in reducing LE significantly. The developing modern surgical management of BCRL has a role in the management of these patients. very low
Smoot 2015 LLLT 2014.10.16 9 LE volume: within-group: −0.52 (−0.78 −0.25); between-groups: −0.62 (−0.97 −0.28) LLLT was associated with clinically relevant within-group reductions in volume and pain. Greater reductions in volume were found in LLLT than that in treatments without it. low
pain: within-group: −0.62 (−1.06 −0.19); between-groups: -1.21 (−4.51, 2.10)
Ridner 2012 Weight reduction 2011 1 The results indicated a significant reduction in swollen arm volume at the end of the 12-week period in the intervention weight-reduction group. Weight loss achieved by dietary advice to reduce energy intake can reduce breast cancer-related LE significantly. low
Toyserkani 2015 stem cells 2014.7.31 2 There was improvement in the volume of LE in autologous stem cells and compression sleeves, with no significant difference. Most studies showed a decrease in LE and an increased lymphangiogenesis when treated with stem cells and this treatment modality has so far shown great potential. very low
There were decreases in LE volume and pain in BMSC transplantation and CPT. BMSC was associated with more decrease than CPT at 3 and 12 months, respectively.
Morris 2013 KTT 2012.4 1 No significant differences for limb size, water composition of the upper-limb, LE-related symptoms and health-related quality of life. In the short-term KTT is no more effective than usual care SSB for BCRL outcomes. low
Dos Santos 2010 acupuncture 2009.4 1 Range of shoulder flexion and abduction, degree of LE volume, heaviness or tightness could be improved after traditional acupuncture. There is a paucity of high quality evidence to support the use of acupuncture to decrease range of motion with LE. very low
Garcia 2014 acupuncture 2011.12 1 Mean reduction in arm circumference difference was 0.90 cm (0.72-1.07). 33% exhibited a reduction of ≥30% without serious adverse events and infections or severe exacerbations. Acupuncture appears to be safe and may reduce arm circumference. very low

LE, lymphedema; CPT, complete decongestive therapy (combined Physical Therapy, complex decongestive physiotherapy, decongestive lymphatic therapy); BMSC, bone marrow stromal cells; IPC, Intermittent Pneumatic Compression Pump; LLLT, low-level laser therapy; MLD, Manual lymphatic drainage; CB, compression bandaging; CS, compression sleeve; SLD, simplified/self-MLD; KTT, Kinesio Tex taping